揭示了阿普罗西坦的碳酸无水酶抑制特征:动力和结构特征
Andrea Angeli1, Marta Ferraroni2, Claudiu T Supuran1
1NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.
ACS medicinal chemistry letters
|August 20, 2025
概括
用于抗性高血压的阿普罗西坦也抑制碳酸酶 (CA),这是一个对血压调节至关重要的酶. 这种双重作用可能会提高其在治疗高血压方面的有效性.
科学领域:
- 生物化学 生物化学
- 药理学 药理学 是一个学科.
- 药用化学 医学化学
背景情况:
- 阿普罗西坦是一种双重内甲素受体抗剂,已被批准用于抗性高血压.
- 它的结构含有一部分硫胺,类似于碳酸酶 (CA) 抑制剂中的结合组.
- 碳酸无水酶在脏和血管生理学中起着关键作用.
研究的目的:
- 调查阿普罗西坦是否通过抑制碳酸无水酶表现出二次药理作用.
- 描述阿普罗西坦与人类碳酸酶异型的相互作用.
主要方法:
- 对所有催化活性的人类CA异型 (hCA I-XIV) 进行阿布罗西坦坦的动力分析.
- 进行X射线晶体学以确定阿布罗西坦与hCA I和hCA II的结合方式.
主要成果:
- 阿普罗西坦对人类碳酸酶异型的抑制活性有明显的表现.
- X射线结构揭示了aprocitentan与hCA I和hCA II结合的分子基础.
- 这表明阿普罗西坦的双重作用机制以前未被识别.
结论:
- 阿普罗西坦具有双重的作用机制,抑制内甲林受体和碳酸无水酶.
- 这种联合作用可能会增强其抗高血压疗效.
- 建议潜在的新疗法策略对抗性高血压涉及CA抑制.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
645
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
645
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
869
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
869
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.4K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.4K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
Adrenergic Receptors: ɑ Subtype
1.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.7K


